Skip to main content
Equibles

BANK OF MONTREAL /CAN/

Bank

Position in SMMT — Summit Therapeutics Inc.

CIK 927971 TORONTO, A6
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,524,384
-$522,517 QoQ
Shares Held
104,625
-3.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 242 holders
Holding Since
Sep 2022
11 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF MONTREAL /CAN/ holds $701,516,965 across 82 Biotechnology names. SMMT ranks #29 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 427,448 $212,326,240
2 HALO
Halozyme Therapeutics, Inc.
 942,432 $73,764,150
3 ARGX
Argenx SE
 77,213 $71,635,902
4 REGN
Regeneron Pharmaceuticals, Inc.
 103,247 $64,378,631
5 JAZZ
Jazz Pharmaceuticals plc
 242,063 $58,329,919
6 TGTX
Tg Therapeutics, Inc.
 515,981 $28,347,995
7 MRNA
Moderna, Inc.
 389,789 $27,296,921
8 CYTK
Cytokinetics Inc
 285,688 $24,337,759

All Filings in SMMT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,524,384 104,625
2026-03-31 $2,046,901 107,959
2025-12-31 $1,668,036 95,371
2025-09-30 $2,025,050 98,018
2025-06-30 $2,139,064 100,520
2025-03-31 $3,549,841 184,025
2024-12-31 $1,502,994 84,225
2024-09-30 $2,136,890 97,575
2024-03-31 $2,440,803 589,566
2023-12-31 $68,642 26,300
2022-09-30 $33,915 28,500